These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9502647)

  • 1. Comparisons of quality of life and cardiac performance after complete atrioventricular junction ablation and atrioventricular junction modification in patients with medically refractory atrial fibrillation.
    Lee SH; Chen SA; Tai CT; Chiang CE; Wen ZC; Cheng JJ; Ding YA; Chang MS
    J Am Coll Cardiol; 1998 Mar; 31(3):637-44. PubMed ID: 9502647
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preserved left ventricular ejection fraction following atrioventricular junction ablation and pacing for atrial fibrillation.
    Chen L; Hodge D; Jahangir A; Ozcan C; Trusty J; Friedman P; Rea R; Bradley D; Brady P; Hammill S; Hayes D; Shen WK
    J Cardiovasc Electrophysiol; 2008 Jan; 19(1):19-27. PubMed ID: 17971146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation.
    Simantirakis EN; Vardakis KE; Kochiadakis GE; Manios EG; Igoumenidis NE; Brignole M; Vardas PE
    J Am Coll Cardiol; 2004 Mar; 43(6):1013-8. PubMed ID: 15028360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.
    Kay GN; Ellenbogen KA; Giudici M; Redfield MM; Jenkins LS; Mianulli M; Wilkoff B
    J Interv Card Electrophysiol; 1998 Jun; 2(2):121-35. PubMed ID: 9870004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiofrequency catheter modification of atrioventricular junction in patients with COPD and medically refractory multifocal atrial tachycardia.
    Ueng KC; Lee SH; Wu DJ; Lin CS; Chang MS; Chen SA
    Chest; 2000 Jan; 117(1):52-9. PubMed ID: 10631199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fixed-rate vs. rate-RESPONSIve pacing on exercise capacity in patients with permanent, refractory atrial fibrillation and left ventricular dysfunction treated with atrioventricular junction aBLation and bivEntricular pacing (RESPONSIBLE): a prospective, multicentre, randomized, single-blind study.
    Palmisano P; Aspromonte V; Ammendola E; Dell'era G; Ziacchi M; Guerra F; Aquilani S; Maglia G; Del Giorno G; Giubertoni A; Boriani G; Capucci A; Pietro Ricci R; Accogli M;
    Europace; 2017 Mar; 19(3):414-420. PubMed ID: 26941340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The influence of radiofrequency (RF) ablation of the atrioventricular junction in atrial fibrillation on left ventricular systolic function, exercise tolerance and quality of life].
    Lelakowski J; Majewski J; Bigaj J; Szczepkowski J; Dreher A; Bednarek J
    Przegl Lek; 2009; 66(5):222-7. PubMed ID: 19739578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leadless pacemaker implantation and concurrent atrioventricular junction ablation in patients with atrial fibrillation.
    Okabe T; El-Chami MF; Lloyd MS; Buck B; Gornick CC; Moore JC; Augostini RS; Hummel JD
    Pacing Clin Electrophysiol; 2018 May; 41(5):504-510. PubMed ID: 29476660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation.
    Gasparini M; Auricchio A; Regoli F; Fantoni C; Kawabata M; Galimberti P; Pini D; Ceriotti C; Gronda E; Klersy C; Fratini S; Klein HH
    J Am Coll Cardiol; 2006 Aug; 48(4):734-43. PubMed ID: 16904542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac resynchronization therapy in patients with permanent atrial fibrillation. Is it mandatory to ablate the atrioventricular junction to obtain a good response?
    Tolosana JM; Arnau AM; Madrid AH; Macias A; Lozano IF; Osca J; Quesada A; Toquero J; Francés RM; Bolao IG; Berruezo A; Sitges M; Alcalá MG; Brugada J; Mont L;
    Eur J Heart Fail; 2012 Jun; 14(6):635-41. PubMed ID: 22396459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atrioventricular Junction Ablation for Atrial Fibrillation.
    Patel D; Daoud EG
    Heart Fail Clin; 2016 Apr; 12(2):245-55. PubMed ID: 26968669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefit of cardiac resynchronization therapy in atrial fibrillation patients vs. patients in sinus rhythm: the role of atrioventricular junction ablation.
    Ferreira AM; Adragão P; Cavaco DM; Candeias R; Morgado FB; Santos KR; Santos E; Silva JA
    Europace; 2008 Jul; 10(7):809-15. PubMed ID: 18511438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presence of contractile reserve has no predictive value for the evolution of left ventricular function following atrio-ventricular node ablation in patients with permanent atrial fibrillation.
    Szili-Torok T; Bountioukos M; Muskens AJ; Theuns DA; Poldermans D; Roelandt JR; Jordaens LJ
    Eur J Echocardiogr; 2005 Oct; 6(5):344-50. PubMed ID: 15975852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of cardiac resynchronization therapy are worse in patients who require atrioventricular junction ablation for atrial fibrillation than in those with sinus rhythm.
    Jędrzejczyk-Patej E; Lenarczyk R; Pruszkowska P; Kowalski O; Mazurek M; Sokal A; Boidol J; Woźniak A; Pluta S; Szulik M; Liberska A; Kalarus Z
    Cardiol J; 2014; 21(3):309-15. PubMed ID: 23990182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter.
    Lee SH; Tai CT; Yu WC; Chen YJ; Hsieh MH; Tsai CF; Chang MS; Chen SA
    Am J Cardiol; 1999 Aug; 84(3):278-83. PubMed ID: 10496435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac resynchronization therapy after atrioventricular junction ablation for symptomatic atrial fibrillation: a meta-analysis.
    Stavrakis S; Garabelli P; Reynolds DW
    Europace; 2012 Oct; 14(10):1490-7. PubMed ID: 22696519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atrio-ventricular junction ablation and pacemaker treatment: a comparison between men and women.
    Carnlöf C; Insulander P; Jensen-Urstad M; Iwarzon M; Gadler F
    Scand Cardiovasc J; 2018 Jun; 52(3):120-126. PubMed ID: 29537317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrioventricular junction ablation for atrial fibrillation.
    Patel D; Daoud EG
    Cardiol Clin; 2014 Nov; 32(4):573-83. PubMed ID: 25443238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased sympathetic activity after atrioventricular junction ablation in patients with chronic atrial fibrillation.
    Hamdan MH; Page RL; Sheehan CJ; Zagrodzky JD; Wasmund SL; Ramaswamy K; Joglar JA; Smith ML
    J Am Coll Cardiol; 2000 Jul; 36(1):151-8. PubMed ID: 10898427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sudden death and its risk factors after atrioventricular junction ablation and pacemaker implantation in patients with atrial fibrillation.
    Wang RX; Lee HC; Li JP; Hodge DO; Cha YM; Friedman PA; Munger TM; Srivathsan K; Pavri BB; Shen WK
    Clin Cardiol; 2017 Jan; 40(1):18-25. PubMed ID: 27748530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.